Qing Zhou

ORCID: 0000-0003-0995-9800
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traditional and Medicinal Uses of Annonaceae
  • Pancreatic function and diabetes
  • Mass Spectrometry Techniques and Applications
  • Cancer-related gene regulation
  • Glycosylation and Glycoproteins Research
  • Natural product bioactivities and synthesis
  • Pharmacogenetics and Drug Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Cancer Research and Treatments
  • RNA modifications and cancer
  • Sesquiterpenes and Asteraceae Studies
  • Ubiquitin and proteasome pathways
  • Epigenetics and DNA Methylation

Women's Hospital, School of Medicine, Zhejiang University
2023

Purdue University West Lafayette
2022

University of California, Davis
2020

Guangdong Provincial People's Hospital
2007

More than 75% of ovarian cancer patients are diagnosed at advanced stages and die tumor cell metastasis. This study aimed to identify new epigenetic transcriptomic alterations associated with metastasis.Two sublines low- high-metastasis potentials were derived from the line A2780. Genome-wide DNA methylome transcriptome profiling carried out in these two by Reduced Representation Bisulfite Sequencing RNA-seq technologies. Cell-based assays conducted support clinical findings.There distinct...

10.3802/jgo.2023.34.e71 article EN cc-by-nc Journal of Gynecologic Oncology 2023-01-01

Abstract UDP-glucose pyrophosphorylase 2 (UGP2) is a lynchpin metabolic enzyme that rests at the convergence of multiple pathways regulating both glycogen synthesis and glycosylation modifications. Here we elucidated essential role UGP2-mediated in maintenance KRAS-driven cancer using vitro vivo models. A key effector KRAS oncogenic function transcription factor YAP. We identified YAP/TEAD complex as major regulator UGP2 mRNA expression enzymatic activity genomic perturbations, correlative...

10.1158/1538-7445.am2020-1470 article EN Cancer Research 2020-08-15
Coming Soon ...